Nano-X Imaging (NASDAQ:NNOX) Stock: Insider Erez Meltzer Purchases 25,000 Shares

Nano-X Imaging Ltd. (NASDAQ:NNOX – Get Free Report) CEO Erez Meltzer acquired 25,000 shares of the business’s stock in a transaction that occurred on Monday, October 19th. The stock was acquired at an average price of $0.45 per share, for a total transaction of $11,250.00. Following the completion of the acquisition, the chief executive officer directly owned 90,443 shares of the company’s stock, valued at $40,699.35. This trade represents a 38.20% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.

Erez Meltzer also recently made the following trade(s):

  • On Tuesday, September 15th, Erez Meltzer bought 10,000 shares of Nano-X Imaging stock. The shares were acquired at an average cost of $0.69 per share, with a total value of $6,900.00.
  • On Thursday, September 10th, Erez Meltzer bought 10,000 shares of Nano-X Imaging stock. The shares were acquired at an average cost of $0.78 per share, with a total value of $7,800.00.
  • On Monday, August 10th, Erez Meltzer bought 9,443 shares of Nano-X Imaging stock. The shares were acquired at an average price of $1.03 per share, with a total value of $9,726.29.
  • On Monday, July 27th, Erez Meltzer bought 36,000 shares of Nano-X Imaging stock. The shares were acquired at an average price of $0.93 per share, with a total value of $33,480.00.

Nano-X Imaging Stock Down 9.5%

NNOX stock opened at $0.41 on Tuesday. The business’s fifty day moving average is $0.74 and its 200-day moving average is $1.32. The company has a market cap of $32.22 million, a P/E ratio of -0.19 and a beta of 1.28. Nano-X Imaging Ltd. has a twelve month low of $0.36 and a twelve month high of $4.71.

Nano-X Imaging (NASDAQ:NNOX – Get Free Report) last announced its quarterly earnings data on Wednesday, September 9th. The company reported ($0.79) EPS for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.63). Nano-X Imaging had a negative return on equity of 116.93% and a negative net margin of 926.05%. The company had revenue of $4.16 million for the quarter, compared to analyst estimates of $5.38 million. Research analysts anticipate that Nano-X Imaging Ltd. will post -1.23 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of NNOX. Engineers Gate Manager LP bought a new position in shares of Nano-X Imaging during the second quarter worth about $42,000. Squarepoint Ops LLC acquired a new stake in Nano-X Imaging in the 2nd quarter valued at approximately $66,000. PCM Encore LLC bought a new stake in Nano-X Imaging in the 2nd quarter valued at approximately $53,000. Bank of America Corp DE lifted its stake in Nano-X Imaging by 711.1% in the 1st quarter. Bank of America Corp DE now owns 484,328 shares of the company’s stock valued at $1,099,000 after acquiring an additional 424,618 shares in the last quarter. Finally, Royal Bank of Canada lifted its stake in Nano-X Imaging by 27.8% in the 1st quarter. Royal Bank of Canada now owns 194,166 shares of the company’s stock valued at $440,000 after acquiring an additional 42,273 shares in the last quarter. Institutional investors own 21.49% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. Zacks Research raised shares of Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. Alliance Global Partners cut shares of Nano-X Imaging from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $5.00 to $3.00 in a research report on Tuesday, July 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $5.00 price objective on shares of Nano-X Imaging in a research note on Monday, August 17th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a report on Friday, October 2nd. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $4.33.

Get Our Latest Stock Report on Nano-X Imaging

About Nano-X Imaging

(Get Free Report)

Nano-X Imaging Ltd. is a medical technology company developing digital X-ray and medical imaging solutions. Its primary product is the Nanox.ARC, a digitally driven X-ray system designed to provide imaging capabilities in hospitals, clinics and other healthcare settings. The company’s approach is intended to support more accessible and affordable diagnostic imaging, including in locations where conventional radiology infrastructure may be limited.

Nano-X also offers cloud-based services through its Nanox.CLOUD platform, which is designed to connect imaging devices, manage examinations and facilitate the transmission and review of medical images.

See Also

Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.